Participation of adult bone marrow-derived stem cells in pancreatic regeneration: Neogenesis versus endogenesis

Current Stem Cell Research and Therapy

Volumn 2, Issue 4, 2007, Pages 272-279

  Iskovich, Svetlana ^a   Kaminitz, Ayelet ^a   Yafe, Michal Pearl ^a   Mizrahi, Keren ^a   Stein, Jerry ^a   Yaniv, Isaac ^a   Askenasy, Nadir ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOXAN; CD45 ANTIGEN; EXENDIN 4; FLT3 LIGAND; GLUCOSE; GLUCOSE TRANSPORTER 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3BETA; INSULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PARVOVIRUS VECTOR; STREPTOZOCIN; TRANSCRIPTION FACTOR PAX6;

ALLOGENIC BONE MARROW TRANSPLANTATION; ALLOXAN DIABETES MELLITUS; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; CELLULAR DISTRIBUTION; CONTINUOUS INFUSION; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RELEASE; INSULIN SYNTHESIS; MYELOABLATIVE CONDITIONING; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REGENERATIVE MEDICINE; REVASCULARIZATION; REVIEW; STEM CELL MOBILIZATION; STREPTOZOCIN DIABETES; TISSUE REGENERATION; VIRAL GENE DELIVERY SYSTEM;

ADULT; ADULT STEM CELLS; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED NOD; PANCREAS; RATS; REGENERATION;

EID: 38349116204     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488807782793754     Document Type: Review

References (132)

1. Swenne I. Pancreatic beta-cell growth and diabetes mellitus. Diabetologia 1992; 35: 193-201.
2. Finegood DT, Scaglia L, Bonner-Weir S. Dynamics of beta-cell mass in the growing rat pancreas. Diabetes 1995; 44: 249-256.
3. Persaud SJ. Pancreatic β-cell lines: their roles in β-cell research and diabetes therapy. In Advances in Molecular and Cell Biology, The Biology of the Pancreatic β-Cell, London: JAI Press Inc. 1999; 29: 21-46.
4. Burns CJ, Persaud SJ, Jones PM. Stem cell therapy for diabetes: do we need to make beta cells? J Endocrinol 2004;183: 437-443.
5. Kume S. Stem-cell-based approaches for regenerative medicine. Dev Growth Differ 2005; 47: 393-402.
6. Madsen OD. Stem cells and diabetes treatment. APMIS 2005; 113: 858-875.
7. Burns CJ, Persaud SJ, Jones PM. Stem-cell therapy for diabetes cure: how close are we? Curt Stem Cell Res Ther 2006; 1: 425-436.
8. Burns CJ, Persaud SJ, Jones PM. Diabetes mellitus: a potential target for stem cell therapy. Current Stem Cell Research & Therapy 2006; 1: 255-266.
9. Santana A, Ensenat-Waser R, Arribas MI, Reig JA, Roche E. Insulin-producing cells derived from stem cells: recent progress and future directions. J Cell Mol Med 2006; 10: 866-883.
10. Pearson T, Markees TG, Serreze DV, et al. Islet cell autoimmunity and transplantation tolerance: two distinct mechanisms? Ann N Y Acad Sci 2003; 1005: 148-156.
11. Rossini AA. Autolmmune diabetes and the circle of tolerance. Diabetes 2004; 53: 267-275.
12. Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 2004; 114: 877-883.
13. Askenasy N, Yolcu ES, Yaniv I, Shirwan H. Fas-ligand as a double-edged immunomodulator to induce transplantation tolerance. Blood 2005; 105: 1396-1404.
14. Sykes M, Nikolic, B. Treatment of severe autommune disease by stem-cell transplantation. Nature 2005; 435: 620-627.
15. Delis S, Burke GW 3rd, Ciancio G. Bone marrow-induced tolerance in the era of pancreas and islets transplantation. Pancreas 2006; 32: 1-8.
16. Van Bekkum D. BMT in experimental autoimmune diseases. Bone Marrow Transplantation 1993; 11: 183-187.
17. Charlton B, Auchincloss H Jr., Fathman CG. Mechanisms of transplantation tolerance. Ann Rev Immunol 1994; 12: 707-734.
18. Good RA. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases. World J Surg 2000; 24: 797-810.
19. Ikehara S. Treatment of autoimmune diseases by hematopoietic stem cell transplantation. Exp Hematol 2001; 29: 661-669.
20. Zorina TD, Subbotin VM, Bertera S, et al. Distinct characteristics and features of allogeneic chimerism in the NOD mouse model of autoimmune diabetes. Cell Transplant 2002; 11: 113-123.
21. Beilhack GF, Scheffold YC, Weissman IL, et al. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice. Diabetes 2003; 52: 59-68
22. Burt RK, Verda L, Oyama Y, Statkute L, Slavin S. Non-myeloablative stem cell transplantation for autoimmune diseases. Springer Semin Immunopathol 2004; 26: 57-69
23. Elkin G, Prigozhina TB, Slavin S. Prevention of diabetes in nonobese diabetic mice by nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol 2004; 32: 579-584.
24. Shi Q, Wang D, Hadley GA, Bingaman AW, Bartlett ST, Farber DL. Long-term islet graft survival in NOD mice by abrogation of recurrent autoimmunity. Diabetes 2004; 53: 2338-2345.
25. Luo B, Nanji SA, Schur CD, Pawlick RL, Anderson CC, Shapiro AM. Robust tolerance to fully allogeneic islet transplants achieved by chimerism with minimal conditioning. Transplantation 2005; 80: 370-377.
26. Sachs DH, Bonner-Weir S. New islets from old. Nat Med 2000; 6: 250-251.
27. Hess D, Li L, Martin M, et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003; 21: 763-770.
28. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003; 302: 1223-1227
29. Li FX, Zhu JW, Tessem JS, et al. The development of diabetes in E2f1 - E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci USA 2003; 100: 12935-12940.
30. Zorina TD, Subbotin VM, Bertera S, et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 2003; 21: 377-388.
31. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429: 41-46.
32. Lee RH, Seo MJ, Reger RL, et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci USA 2006; 103: 17438-17443.
33. Rood PP, Bottino R, Balamurugan AN, Fan Y, Cooper DK, Trucco M. Facilitating physiologic self-regeneration: a step beyond islet cell replacement. Pharm Res 2006; 23: 227-242.
34. Kang EM, Zickler PP, Burns S, et al. Hematopoietic stem cell transplantation prevents diabetes in NOD mice but does not contribute to significant islet cell regeneration once disease is established. Exp Hematol 2005; 33: 699-705.
35. Hering BJ, Kandaswamy R, Ansite JD, et al. Single donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
36. Shapiro AM, Lakey JR, Paty BW, Senior PA, Bigam DL, Ryan EA. Strategic opportunities in clinical islet transplantation. Transplantation 2005.79: 1304-1307.
37. Shapiro AM, Ricordi C, Hering BJ, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355: 1318-1330.
38. Li H, Kaufman CL, Ildstad ST. Allogeneic chimerism induces donor-specific tolerance to simultaneous islet allografts in nonobese diabetic mice. Surgery 1995; 118: 192-198.
39. Wu T, Levay-Young B, Heuss N, et al. Inducing tolerance to MHC-matched allogeneic islet grafts in diabetic NOD mice by simultaneous islet and bone marrow transplantation under nonirradiative and nonmyeloablative conditioning therapy. Transplantation 2002; 74: 22-27.
40. Taira M, Inaba M, Takada K, et al. Treatment of streptozotocin-induced diabetes mellitus in rats by transplantation of islet cells from two major histocompatibility complex disparate rats in combination with intra bone marrow injection of allogeneic bone marrow cells. Transplantation 2005; 79: 680-687.
41. Matsumoto S, Okitsu T, Iwanaga Y, et al. Insulin independence after living-donor distal pancreatectomy and islet allotransplantation. Lancet 2005; 365: 1642-1644.
42. Korbling M, Estrov Z. Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 2003; 349: 570-582.
43. Efrat S. Genetically engineered pancreatic b-cell lines for cell therapy of diabetes. Ann NY Acad Sci 1999; 875: 286-293.
44. Kahn A. Converting hepatocytes to b-cells - a new approach for diabetes? Nat Med 2000; 6: 505-506.
45. Tosh D, Shen CN, Slack JM. Differentiated properties of hepatocytes induced from pancreatic cells. Hepatology 2002; 36: 534-543.
46. Tosh D, Slack JMW. How cells change their phenotype. Nature Rev: Mol Cell Biol 2002; 3: 187-194.
47. Itkin-Ansari P, Geron I, Hao E, Demeterco E, Tyberg B, Levine F. Cell-based therapies for diabetes: progress towards a transplantable human (beta) cell line. Ann NY Acad Sci 2003; 1005: 138-147.
48. Lechner A, Habener JF. Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. AJP: Endocrinol Metab 2003; 284: E259-266.
49. Polonsky KS, Bell GI. Organ alchemy: producing insulin in the liver. Nat Med 2003; 9: 504-505.
50. Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet 2004; 364: 203-205.
51. Robertson RP. Islet Transplantation as a treatment for diabetes - a work in progress N Engl J Med 2004; 350: 694-705.
52. Soria B, Bedoya FJ, Martin F. Gastrointestinal stem cells I. Pancreatic stem cells. Am J Physiol Gastrointest Liver Physiol 2005; 289: G177-G180.
53. Pearl-Yafe M, Yolcu ES, Yaniv I, Stein J, Shirwan. H, Askenasy N. The role of Fas ligand in diabetes and islet transplant: injury effector or defense strategy? BioEssays 2006; 28: 1-12.
54. Cheung AT, Dayanandan B, Lewis IT, et al. Glucose-dependent insulin release from genetically engineered K cells. Science 2000; 290: 1959-1962.
55. Tuch BE, Szymanska B, Yao M et al. Function of a genetically modified human liver cell line that stores, processes and secretes insulin. Gene Ther 2003; 10: 490-503.
56. Zalzman M, Gupta S, Giri RK, et al. Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci USA 2003; 100: 7253-7258.
57. Okitsu T, Kobayashi N, Jun HS, et al. Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes 2004; 53: 105-112.
58. Choi JB, Uchino H, Azuma K, et al. Little evidence of transdifferentiation of bone marrow-derived cells into pancreatic beta cells. Diabetologia 2003; 46: 1366-1374.
59. Lechner A, Yang YG, Blacken RA, Wang L, Nolan AL, Habener JF. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004; 53: 616-623.
60. Taneera J, Rosengren A, Renstrom E, et al. Failure of transplanted bone marrow cells to adopt a pancreatic beta-cell fate. Diabetes 2006; 55: 290-296
61. Mathews V, Hanson PT, Ford E, Fujita J, Polonsky KS, Graubert TA. Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes 2004; 53: 91-98.
62. Ianus A, Holz GG, Theise ND, Hussain MA. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003; 111: 843-850.
63. Yoshida S, Ishikawa. F, Kawano N, et al. Human cord blood-derived cells generate insulin-producing cells in vivo. Stem Cells 2005; 23: 1409-1416.
64. Abedi M, Greer DA, Colvin GA, et al. Tissue injury in marrow transdifferentiation. Blood Cells Mol Dis 2004; 32: 4246.
65. Ogawa M, Matsuzaki Y, Nishikawa S, et al. Expresion and function of c-Kit in hemopoietic progenitor cells. J Exp Med 1991; 174: 63-71.
66. Stoffers DA, Heller RS, Miller CP, Habener JF. Developmental expression of the homeodomain protein IDX-1 in mice transgenic for an IDX-1 promoter/lacZ transcriptional reporter. Endocrinology 1999; 140: 5374-5381.
67. Broxmeyer HE, Lu L, Cooper S, Ruggieri L, Li ZH, Lyman SD. Flt3 tigand stimulates/costimulates the growth of myeloid stem/progenitor cells. Exp Hematol 1995; 23: 1121-1129.
68. Ende N, Chen R, Reddi AS. Effect of human umbilical cord blood cells on glycemia and insulitis in type 1 diabetic mice. Biochem Biophys Res Commun 2004; 325: 665-669.
69. Banerjee M, Kumar A, Bhonde RR. Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 2005; 328: 318-325.
70. Biankin SA, Collector MI, Biankin AV, et al. A histological survey of green fluorescent protein expression in 'green' mice: implications for stem cell research. Pathology 2007; 39: 247-251.
71. McTaggart RA, Feng S. An uncomfortable silence em leader while we all search for a better reporter gene in adult stem cell biology. Hepatology 2004; 39: 1143-1146.
72. Anderson DA, Wu Y, Jiang S, et al. Donor marker infidelity in transgenic hematopoietic stem cells. 2005; 23: 638-643.
73. Toth ZE, Shahar T, Leker F, et al. Sensitive detection of GFP utilizing tyramide signal amplification to overcome gene silencing. Exp Cell Res 2007; 313: 1943-1950.
74. Brazelton TR, Blau HM. Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells 2005; 23: 1251-1265.
75. Francois S, Bensidhoum M, Mouiseddine M, et al. Local irradiation not only induces homing of human mesenchymal stem cells at exposed sites but promotes their widespread engraftment to multiple organs: a study of their quantitative distribution after irradiation damage. Stem Cells 2006; 24: 1020-1029.
76. Sipione S, Eshpeter A, Lyon JG, Korbut: GS, Bleackley RC. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 2004; 47: 499-508.
77. Fujikawa T, Oh SH, Pi L, Hatch HM, Shupe T, Petersen BE. Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am J Pathol 2005; 166: 1781-1791.
78. Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 2003; 21: 257-265
79. Drukker M, Katz G, Urbach A, et al. Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 9864-9869.
80. Drukker M, Benvenisty N. The immunogenicity of human embryonic stem-derived cells. Trends Biotechnol 2004; 22: 136-141.
81. Tang DQ, Cao LZ, Burkhardt BR, et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004; 53: 1721-1732.
82. Terada N, Hamazaki T, Oka M, et al. Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature 2002; 416: 542-545.
83. Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM, et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425: 968-973
84. Medvinsky A, Smith A. Fusion brings down barriers. Nature 2003; 422: 823-825.
85. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003; 422: 901-904.
86. Wang X, Willenbring H, Akkari Y, et al. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 2003; 422: 897-901.
87. Camargo FD, Finegold M, Goodell MA. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 2004; 113: 1266-1270.
88. Shah R, Jindal RM. Reversal of diabetes in the rat by injection of hematopoietic stem cells infected with recombinant adeno-associated virus containing the preproinsulin II gene. Pancreatology 2003; 3: 422-428.
89. Ferber S, Halkin A, Cohen H, et al. Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med 2000; 6: 568-572.
90. Lee HC, Kim SJ, Kim KS, Shin HC, Yoon JW. Remission in models of type 1 diabetes by gene therapy using a single chain insulin-analogue. Nature 2000; 408: 483-488.
91. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
92. D'Ippolito G, Diabira S, Howard GA, Menei P, Roos BA, Schiller PC. Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential. J Cell Sci 2004; 117: 2971-2981
93. Moriscot C, de Fraipont F, Richard MJ, et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005; 23: 594-603.
94. Pessina A, Eletti B, Croera C, Savalli N, Diodovich C, Gribaldo L. Pancreas developing markers expressed on human mononucleated umbilical cord blood cells. Biochem Biophys Res Commun 2004; 323: 315-322.
95. Zulewski H, Abraham EJ, Gerlach MJ, et al. Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes 2001; 50: 521-533
96. Street CN, Lakey JR, Seeberger K, et al. Heterogeneous expression of nestin in human pancreatic tissue preclude use as an islet precursor marker. J Endocrinol 2004; 180: 213-225.
97. Bort R, Zaret K. Paths to the pancreas. Nat Genet 2002; 32: 85-86
98. Edlund H. Pancreatic organogenesis - developmental mechanisms and implications for therapy. Nat Rev Genet 2002; 3: 524-532
99. Wilson ME, Scheel D, German MS. Gene expression cascades in pancreatic development. Mech Dev 2003; 120: 65-80
100. Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn 2004; 229: 176-200.
101. Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell 2000; 100: 157-168.
102. Lakshmipathy U, Verfaillie C. Stem cell plasticity. Blood Rev 2005; 19: 29-38.
103. Wagers AJ, Weissman IL. Plasticity of adult stem cells. Cell 2004; 116: 639-648.
104. Lee VM, Stoffel M. Bone marrow: an extra-pancreatic hideout for the elusive pancreatic stem cell? J Clin Invest 2003; 111: 799-801.
105. Kucia M, Reca R, Jala VR, Dawn B, Ratajczak J, Ratajczak MZ. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 2005; 19: 1118-1127.
106. Krause DS, Theise ND, Collector MI, et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105: 369-377.
107. Corbel SY, Lee A, Yi L, et al. Contribution of hematopoietic stem cells to skeletal muscle. Nat Med 2003; 9: 1528-1532.
108. Moore BE, Quesenberry PJ. The adult hemopoietic stem cell plasticity debate: idols vs new paradigms. Leukemia 2003; 17: 1205-1210.
109. Jang YY, Sharkis SJ. Metamorphosis from bone marrow derived primitive stem cells to functional liver cells. Cell Cycle 2004; 3: 980-982.
110. Zipori D. The nature of stem cells: state rather than entity. Nat Rev Genet 2004; 5: 873-878
111. Fuchs E, Segre JA. Stem cells: a new lease on life. Cell 2000; 100: 143-155.
112. Blau HM, Brazelton TF, Weimann JM. The evolving concept of a stem cell: entity or function? Cell 2001; 105: 829-841.
113. Orkin SH, Zon LI. Hematopoiesis and stem cells: plasticity versus developmental heterogeneity. Nat Immunol 2002; 3: 323-328.
114. Quesenberry PJ, Colvin GA, Abedi M, et al. The marrow stem cell: the continuum. Bone Marrow Transplant 2003; 32(Suppl 1): S19-S22.
115. Lambert JF, Liu M, Colvin GA, et al. Marrow stem cells shift gene expression and engraftment phenotype with cell cycle transit. J Exp Med 2003; 197: 1563-1572.
116. Orkin SH. Priming the hematopoietic pump. Immunity 2003; 19: 633-634.
117. Colvin GA, Lambert JF, Moore BE, et al. Intrinsic hematopoietic stem cell/progenitor plasticity: Inversions. J Cell Physiol 2004; 199: 20-31.
118. Zipori D. The stem state: Plasticity is essential, whereas self-renewal and hierarchy are optional. Stem Cells 2005; 23: 719-726.
119. Askenasy N, Stein J, Yaniv I, Sharkis SJ. Our perception of developmental plasticity. Esse est percipi (to be is to be perceived)? Cur Stem Cell Res Ther 2006; 1: 85-94.
120. Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 2002; 69: 908-917.
121. Gershengorn MC, Hardikar AA, Wei C, Geras-Raaka E, Marcus-Samuels B, Raaka BM. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004; 306: 2261-2264.
122. Pochampally RR, Smith JR, Ylostalo J. Prockop DJ. Serum deprivation of human marrow stromal cells (hMSCs) selects for a sub-population of early progenitor cells with enhanced expression of Oct-4 and other embryonic genes. Blood 2004; 103: 1647-1652.
123. Zhang L, Hong TP, Hu J, Liu YN, Wu YH, Li LS. Nestin-positive progenitor cells isolated from human fetal pancreas have phenotypic markers identical to mesenchymal stem cells. World J Gastroenterol 2005; 11: 2906-2911.
124. Lumelsky N, Blondel O, Laeng P, Velasco I, Ravin R, McKay R. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001; 292: 1389-1394.
125. Seaberg RM, Smukler SR, Kieffer TJ, et al. Clonal identification of multipotent precursors from adult mouse pancreas that generate neural and pancreatic lineages. Nat Biotechnol 2004; 22: 1115-1124.
126. Burns CJ, Minger SL, Hall S, et al. The in vitro differentiation of rat neural stem cells into an insulin-expressing phenotype. Biochem Biophys Res Commun 2005; 326: 570-577.
127. Harmon EB, Apelqvist AA, Smart NG, Gu X, Osborne DH, Kim SK. GDF11 modulates NGN3+ islet progenitor cell number and promotes beta-cell differentitition in pancreas development. Development. 2004;131(24): 6163-74.
128. Brolen GKC, Heins N, Edsbagge J, Semb H. Signals from the embryonic mouse pancreas induce differentiation of human embryonic stem cells into insulin-producing {beta}-cell-like cells. Diabetes 2005; 54: 2867-2874.
129. Vaca P, Martin F, Vegara-Meseguer JM, Rovira JM, Berna G, Soria B. Induction of differentiation of embryonic stem cells into insulin-secreting cells by fetal soluble factors. Stem Cells 2006; 24: 258-265.
130. Quesenberry PJ, Donner G, Dooner M, Abedi M. Developmental biology: Ignoratio elenchi: red herrings in stem cell research. Science 2005; 308: 1121-1122.
131. Jang YY, Collector MI, Baylin SB, Diehl AM, Sharkis SJ. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 2004; 6: 532-539.
132. Askenasy N. From the atom to the cell: Is the cat alive? Quantum mechanics and stem cell plasticity as deja vu. Stem Cells Dev 2006; 15: 488-991